↓ Skip to main content

Vincristine-induced vocal cord palsy and successful re-treatment in a patient with diffuse large B cell Lymphoma: a case report

Overview of attention for article published in BMC Research Notes, May 2014
Altmetric Badge

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Vincristine-induced vocal cord palsy and successful re-treatment in a patient with diffuse large B cell Lymphoma: a case report
Published in
BMC Research Notes, May 2014
DOI 10.1186/1756-0500-7-318
Pubmed ID
Authors

Zarka Samoon, Munira Shabbir-Moosajee

Abstract

Vincristine, a type of vinca alkaloid, is widely used in the treatment of various childhood and adult malignancies. A well-known side effect of vincristine is its neurotoxicity and it is rarely indicted in vagus nerve involvement. Vincristine induced vocal cord palsy is a potentially reversible condition, with the mainstay of therapy being withdrawal of the offending drug. However, there are no clear guidelines regarding the possibility of re-treatment with the causative agent.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Unknown 30 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 23%
Other 5 16%
Student > Doctoral Student 3 10%
Student > Ph. D. Student 3 10%
Student > Postgraduate 3 10%
Other 5 16%
Unknown 5 16%
Readers by discipline Count As %
Medicine and Dentistry 16 52%
Nursing and Health Professions 5 16%
Business, Management and Accounting 1 3%
Arts and Humanities 1 3%
Agricultural and Biological Sciences 1 3%
Other 1 3%
Unknown 6 19%